Citation
Park, Sun-Hee, et al. "Erythropoietin Decreases Renal Fibrosis in Mice With Ureteral Obstruction: Role of Inhibiting TGF-beta-induced Epithelial-to-mesenchymal Transition." Journal of the American Society of Nephrology : JASN, vol. 18, no. 5, 2007, pp. 1497-507.
Park SH, Choi MJ, Song IK, et al. Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition. J Am Soc Nephrol. 2007;18(5):1497-507.
Park, S. H., Choi, M. J., Song, I. K., Choi, S. Y., Nam, J. O., Kim, C. D., Lee, B. H., Park, R. W., Park, K. M., Kim, Y. J., Kim, I. S., Kwon, T. H., & Kim, Y. L. (2007). Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition. Journal of the American Society of Nephrology : JASN, 18(5), 1497-507.
Park SH, et al. Erythropoietin Decreases Renal Fibrosis in Mice With Ureteral Obstruction: Role of Inhibiting TGF-beta-induced Epithelial-to-mesenchymal Transition. J Am Soc Nephrol. 2007;18(5):1497-507. PubMed PMID: 17389738.
TY - JOUR
T1 - Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition.
AU - Park,Sun-Hee,
AU - Choi,Min-Jeong,
AU - Song,In-Kyung,
AU - Choi,Soon-Youn,
AU - Nam,Ju-Ock,
AU - Kim,Chan-Duck,
AU - Lee,Byung-Heon,
AU - Park,Rang-Woon,
AU - Park,Kwon Moo,
AU - Kim,Yong-Jin,
AU - Kim,In-San,
AU - Kwon,Tae-Hwan,
AU - Kim,Yong-Lim,
Y1 - 2007/03/27/
PY - 2007/3/29/pubmed
PY - 2007/8/8/medline
PY - 2007/3/29/entrez
SP - 1497
EP - 507
JF - Journal of the American Society of Nephrology : JASN
JO - J Am Soc Nephrol
VL - 18
IS - 5
N2 - The inhibitory effects of recombinant human erythropoietin (rhEPO) were examined against (1) the progression of renal fibrosis in mice with complete unilateral ureteral obstruction and (2) the TGF-beta1-induced epithelial-to-mesenchymal transition (EMT) in MDCK cells. Unilateral ureteral obstruction was induced in BALB/c mice and rhEPO (100 or 1000 U/kg, intraperitoneally, every other day) or vehicle was administered from day 3 to day 14. Immunoblotting and immunohistochemistry revealed increased expressions of TGF-beta1, alpha-smooth muscle actin (alpha-SMA), and fibronectin and decreased expression of E-cadherin in the obstructed kidneys. In contrast, rhEPO treatment significantly attenuated the upregulation of TGF-beta1 and alpha-SMA and the downregulation of E-cadherin. MDCK cells were treated with TGF-beta1 (5 ng/ml) for 48 h to induce EMT, and the cells were then co-treated with TGF-beta1 and rhEPO for another 48 h. Increased expressions of alpha-SMA and vimentin and decreased expressions of zona occludens-1 and E-cadherin were observed after TGF-beta1 treatment, and these changes were markedly attenuated by rhEPO co-treatment. TGF-beta1 increased phosphorylated Smad-2 expression in MDCK cells, which was decreased by rhEPO co-treatment. In conclusion, rhEPO treatment inhibits the progression of renal fibrosis in obstructed kidney and attenuates the TGF-beta1-induced EMT. It is suggested that the renoprotective effects of rhEPO could be mediated, at least partly, by inhibition of TGF-beta1-induced EMT.
SN - 1046-6673
UR - https://www.unboundmedicine.com/medline/citation/17389738/Erythropoietin_decreases_renal_fibrosis_in_mice_with_ureteral_obstruction:_role_of_inhibiting_TGF_beta_induced_epithelial_to_mesenchymal_transition_
L2 - https://jasn.asnjournals.org/cgi/pmidlookup?view=long&pmid=17389738
DB - PRIME
DP - Unbound Medicine
ER -